Page 12 - Technical Charts

Here's why Mehul Kothari recommends buying Gland Pharma, Indian Oil

According to the technical analyst from Anand Rathi, Gland Pharma can rally to Rs 2,350, while IOC can spurt to Rs 83.

Contra bets in HCL Tech and Wipro could give up to 20% gains; Here's why

If Wipro fails to defend the 200-WMA placed at Rs 378, the stock can slide to near Rs 300-mark. On the other hand, HCL Technologies seems to be on course to test Rs 1,200.

Can Bira 91 deal trigger gains for alcohol stocks? Here's what charts say

After an exciting 2021, shares of major alcohol manufacturers have been under pressure so far this year. Here's what charts suggest is in store for them

MCX Crude Oil may turn rangebound; Natural Gas tests key support at Rs 520

The MCX Crude Oil futures are likely to trade in a broad range of Rs 6,900 - Rs 7,770 in the near term. Natural Gas futures can pullback to Rs 580, is support at Rs 520 is sustained.

Here's why Vinay Rajani is bullish on KIMS, Pfizer; bearish on Nifty

On the broader market outlook, the technical analyst from HDFC Securities says that the indicators and oscillators have turned bearish on the short term charts for the Nifty 50.

TCS needs to breakout over Rs 3,150-level for fresh rally, chart says

There is an "Inverse Head and Shoulder" pattern getting established on the daily chart. Technically, this pattern breakout over Rs 3,150 levels would add aggressive bets on the stock.

Mehul Kothari recommends Buy on CAMS, Pfizer; Check Why

According to the technical analyst from Anand Rathi, CAMS can rally to Rs 2,700, while Pfizer can be bought for a target of Rs 4,700.

Ahead of rights issue, charts hint steady gains for Suzlon; 200-DMA is key

There is a bullish formation of a "Higher High, Higher Low" pattern on the daily chart, and only if the stock breaks the 200-DMA the trend could turn negative.

Vedanta, JSW can soar up to 18% as Nifty Metal eyes 'Golden Cross' breakout

The Nifty Metal index can rally up to 11 per cent following the breakout. Among individual stocks, Tata Steel needs to conquer its 200-DMA to gain strength.

Support for Gold moves higher to Rs 50,800; MCX Silver may test Rs 63,900

The MCX Silver futures were seen testing the 200-DMA after a gap of almost six months and could move to Rs 63,900-level in the near term.

Brickwork impact: Charts favour Icra; CRISIL, CARE Ratings test key levels

ICRA and CRISIL have gained up to 22 per cent so far this year, while Care Ratings has been a underperformer, down 14 per cent.

Mehul Kothari recommends these 2 stocks on 'Symmetrical Triangle' breakout

According to the technical analyst from Anand Rathi, Godfreh Phillips can jump to Rs 1,320, while Zydus Wellness can be bought for a target of Rs 1,860.

Manyavar, Cipla: 11 stocks that could hold ground even if market corrects

Amid the recent market fall,11 stocks hit record highs. Whenever any stock exhibits reluctantance to weaken despite a pessimistic bias, it means the underlying trend possesses a robust momentum.

MCX Crude Oil can pullback to Rs 7,700; Natural Gas likely to test Rs 600

The pullback in MCX Crude Oil futures is aided by cut in oil production by OPEC+ members. The commodity crossed its 50-DMA for the first time since July 2022.

Vinay Rajani of HDFC Securities expects markets to remain bullish for now

Among individual stocks, the technical analyst recommends buying JK Tyre and J.B.Chemicals & Pharma.

Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

The Pharma benchmark has outperformed the overall market in recent trading sessions; sustenance above 200-DMA is likely to trigger further gains for it

Trading Strategies in Bandhan Bank, Eris Lifesciences by Mehul Kothari

According to the technical analyst from Anand Rathi, Bandhan Bank can be shorted for a price target of Rs 272, while Eris Lifesciences can be bought for a target of Rs 800.

Post rate hike by RBI, SBI, BoB look stronger than private banks on charts

Public sector banks are well placed on charts, indicate positive upside in coming days, while Private Banks rigorously need to take off their respective hurdles.

Derivatives analyst Nandish Shah recommends selling Axis Bank futures

The analyst from HDFC Securities recommends selling Axis Bank October contract on rise with a stop loss at Rs 745, for a downside target of Rs 705.

LIC, Nykaa, Tata Motors: Are these buzzing stocks bottoming out?

Sun Pharmaceutical seems set to register a new 52-week high; while Tata Motors and Torrent Pharmaceuticals are yet to take-off their respective obstacles, charts show.